Powered by Advanced and Clinically Tested Bioprinting Technologies
PrintBio, in collaboration with leading surgeons, is pioneering advanced 3D printing technologies to deliver innovative surgical solutions. This vision comes to life with a two-brand portfolio of Programmable Surgical Mesh (PSM) – DynaFlex™ PSM and DynaForm™ PSM. Each delivers unique characteristics and benefits in surgical repair and reinforcement of soft tissue. While both brands offer broad customizability across clinically relevant scenarios, DynaFlex™ PSM specializes in empowering surgeons to precisely tailor flexibility and stability in any direction, or within targeted zones of the mesh through its MetaFlex™ technology. While embodying similar properties, DynaForm™ PSM delivers three-dimensional (3D) mesh constructs designed to provide immediate soft tissue support as well as a basis for long-term strength.
Our Products
PrintBio has developed unique capabilities, materials and technologies that enabled the creation of the first ever living tissue implants implanted in patients.
Leveraging this material science, regulatory and clinical experience, PrintBio is launching its first products that provides physicians with unprecedented capabilities in managing their patients. 3DMatrix DynaFlex™ and DynaForm™, our next generation products, both add PrintBio’s proprietary MetaDirectional Flex™ capabilities to its first ever 3D-printed bioresorbable surgical mesh technology.
Investor Relations
Corporate Profile
PrintBio is a clinical- and commercial-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and material science technologies to deliver safe, functional and personalized products, and living tissues and organs, engineered and produced on-demand for patients.
